Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -7.353M
March 31, 2026 -9.165M
December 31, 2025 -9.894M
September 30, 2025 -10.59M
June 30, 2025 -10.61M
March 31, 2025 -11.18M
December 31, 2024 -13.54M
September 30, 2024 -15.26M
June 30, 2024 -18.25M
March 31, 2024 -21.47M
December 31, 2023 -26.80M
September 30, 2023 -36.33M
Date Value
June 30, 2023 -45.86M
March 31, 2023 -56.43M
December 31, 2022 -55.55M
September 30, 2022 -53.28M
June 30, 2022 -47.11M
March 31, 2022 -38.58M
December 31, 2021 -28.95M
September 30, 2021 -19.52M
June 30, 2021 -13.41M
March 31, 2021 -4.003M
December 31, 2020 -2.961M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
MetaStat, Inc. --
Lifecore Biomedical, Inc. --
Repligen Corp. 110.15M
Bio-Techne Corp. 263.22M
Codexis, Inc. -12.18M